Literature DB >> 19060447

Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus.

Zenei Arihara1, Kanako Sakurai, Shozo Yamada, Osamu Murakami, Kazuhiro Takahashi.   

Abstract

Acromegaly is characterized by the somatic disfigurement and excessive production of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Here we report a patient with aromegaly and diabetes mellitus, who showed normal IGF-1 levels in spite of elevated GH levels. The patient was a 52-year-old woman with acromegalic manifestations. Serum GH level was elevated (32.4 ng/mL) with hyperglycemia (fasting plasma glucose, 277 mg/dL) and an extremely high level of glycosylated hemoglobin (HbA1c 17.7%), whereas serum IGF-1 level was within normal range (110 ng/mL, normal range 37-266). Brain magnetic resonance imaging detected a pituitary tumor, with involvement of the right cavernous sinus. Oral glucose tolerance test (OGTT) showed no suppression of serum GH. Thyrotropin-releasing hormone test showed paradoxical increases in serum GH. We therefore diagnosed acromegaly accompanied with diabetes mellitus. A large amount of insulin (34 units/day) was required to control the blood glucose level. The patient was treated with octreotide, a somatostatin analogue, followed by transsphenoidal surgery. After the surgery, serum GH levels were suppressed by OGTT, although basal serum GH levels remained to be high. Basal serum GH levels, however, were normalized 5 months later. Blood glucose became well controlled by the diet alone. In contrast, serum IGF-1 increased to the range of 219-233 ng/mL. Pre-operative serum IGF-1 levels were low probably due to poorly controlled diabetes mellitus. In conclusion, the presence of normal serum IGF-1 levels cannot exclude the diagnosis of acromegaly especially when the patient is accompanied by diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060447     DOI: 10.1620/tjem.216.325

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  5 in total

1.  Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism?

Authors:  Georgiana Dobri; Soamsiri Niwattisaiwong; James F Bena; Manjula Gupta; John Kirwan; Lawrence Kennedy; Amir H Hamrahian
Journal:  Endocrine       Date:  2018-11-10       Impact factor: 3.633

2.  Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population.

Authors:  Pedro Weslley Rosario
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

3.  Medical therapy of acromegaly.

Authors:  U Plöckinger
Journal:  Int J Endocrinol       Date:  2012-04-10       Impact factor: 3.257

4.  Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report.

Authors:  Dilushi Rowena Wijayaratne; M H Arambewela; Chamara Dalugama; Dishni Wijesundera; Noel Somasundaram; Prasad Katulanda
Journal:  J Med Case Rep       Date:  2015-10-30

5.  Acromegaly with Normal Insulin-Like Growth Factor-1 Levels and Congestive Heart Failure as the First Clinical Manifestation.

Authors:  Hyae Min Lee; Sun Hee Lee; In Ho Yang; In Kyoung Hwang; You Cheol Hwang; Kyu Jeung Ahn; Ho Yeon Chung; Hui Jeong Hwang; In Kyung Jeong
Journal:  Endocrinol Metab (Seoul)       Date:  2015-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.